Oxbridge Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement

Core Viewpoint - Oxbridge Re Holdings Limited has announced a securities purchase agreement to raise approximately $3.0 million through a registered direct offering and a concurrent private placement of ordinary shares and warrants [1][2]. Group 1: Offering Details - The company will issue 705,884 ordinary shares at an effective offering price of $4.25 per share, along with Series A Warrants for 529,413 shares and Series B Warrants for 882,355 shares [1][2]. - The Series A Warrants are immediately exercisable with a two-year expiration and an exercise price of $4.25 per share, while the Series B Warrants will be exercisable upon shareholder approval or six months from issuance, expiring five years from the initial exercise date [1][2]. Group 2: Financial Proceeds - The total gross proceeds from the offering are estimated to be around $3.0 million before deducting fees and expenses [2]. Group 3: Regulatory Compliance - The ordinary shares are being offered under a shelf registration statement declared effective by the SEC on September 6, 2022, and will be made available through a prospectus supplement [3]. - The Series A and Series B Warrants are offered in a private placement under Section 4(a)(2) of the Securities Act and have not been registered under the Act or applicable state laws [4]. Group 4: Company Overview - Oxbridge Re Holdings Limited is based in the Cayman Islands and specializes in tokenized Real-World Assets (RWAs) and reinsurance solutions for property and casualty insurers [6]. - The company operates through subsidiaries, including SurancePlus Inc., which has developed the first "on-chain" reinsurance RWA, making reinsurance more accessible to investors [8].